Hypofractionated radiation therapy versus conventionally fractionated radiation therapy for early-stage breast cancer: how do we choose?

[1]  B. Robinson,et al.  Hypofractionated radiation treatment following mastectomy in early breast cancer: The Christchurch experience , 2015, Journal of medical imaging and radiation oncology.

[2]  M. McBride,et al.  Long-term mortality from cardiac causes after adjuvant hypofractionated vs. conventional radiotherapy for localized left-sided breast cancer. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  E. Rakovitch,et al.  Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breast. , 2014, International journal of radiation oncology, biology, physics.

[4]  C. Gross,et al.  Adoption of hypofractionated whole-breast irradiation for early-stage breast cancer: a National Cancer Data Base analysis. , 2014, International journal of radiation oncology, biology, physics.

[5]  C. Papadimitriou,et al.  Adjuvant chemotherapy and acute toxicity in hypofractionated radiotherapy for early breast cancer. , 2014, World journal of clinical cases.

[6]  M. McBride,et al.  Adjuvant hypofractionated versus conventional whole breast radiation therapy for early-stage breast cancer: long-term hospital-related morbidity from cardiac causes. , 2014, International journal of radiation oncology, biology, physics.

[7]  Pranshu Mohindra,et al.  Dose-limiting toxicity after hypofractionated dose-escalated radiotherapy in non-small-cell lung cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  R. Stoyanova,et al.  Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  L. Strigari,et al.  Evidence from a breast cancer hypofractionated schedule: late skin toxicity assessed by ultrasound , 2013, Journal of Experimental & Clinical Cancer Research.

[10]  Joanne S Haviland,et al.  The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. , 2013, The Lancet. Oncology.

[11]  T. Buchholz,et al.  Hypofractionated breast radiation: preferred standard of care? , 2013, The Lancet. Oncology.

[12]  T. Whelan,et al.  A population-based study of the fractionation of postlumpectomy breast radiation therapy. , 2013, International journal of radiation oncology, biology, physics.

[13]  R. Santoni,et al.  Standard or hypofractionated radiotherapy in the postoperative treatment of breast cancer: a retrospective analysis of acute skin toxicity and dose inhomogeneities , 2013, BMC Cancer.

[14]  Guy Storme,et al.  Health-related quality of life in survivors of stage I-II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapy , 2012, BMC Cancer.

[15]  Y. Lievens.  Hypofractionated breast radiotherapy: financial and economic consequences. , 2010, Breast.

[16]  B. Hickey,et al.  Hypofractionated Whole‐Breast Radiotherapy: Impact on Departmental Waiting Times and Cost , 2010, Journal of medical imaging and radiation oncology.

[17]  J. Haviland,et al.  The course of anxiety and depression over 5 years of follow-up and risk factors in women with early breast cancer: results from the UK Standardisation of Radiotherapy Trials (START). , 2010, Breast.

[18]  Anthony Fyles,et al.  Long-term results of hypofractionated radiation therapy for breast cancer. , 2010, The New England journal of medicine.